Follow-up of blood-pressure lowering and glucose control in type 2 diabetesNew England Journal of Medicine
Date of this Version10-9-2015
Document TypeJournal Article
AbstractThe benefits with respect to mortality that had been observed among patients originally assigned to blood-pressure–lowering therapy were attenuated but still evident at the end of follow-up. There was no evidence that intensive glucose control during the trial led to long-term benefits with respect to mortality or macrovascular events.
Citation InformationSophia Zoungas, John Chalmers, Bruce Neal, Laurent Billot, et al.. "Follow-up of blood-pressure lowering and glucose control in type 2 diabetes" New England Journal of Medicine (2015) ISSN: 0028-4793
Available at: http://works.bepress.com/paul_glasziou/158/